Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study
Therapeutic Advances in Psychopharmacology
Published online on April 21, 2026
Abstract
Therapeutic Advances in Psychopharmacology, Volume 16, XX 2026.
Background:Treatment-resistant depression (TRD) remains a major clinical challenge, and long-term real-world data on intranasal esketamine are limited.Objectives:To describe long-term dosing patterns and clinical outcomes associated with intranasal ...
Background:Treatment-resistant depression (TRD) remains a major clinical challenge, and long-term real-world data on intranasal esketamine are limited.Objectives:To describe long-term dosing patterns and clinical outcomes associated with intranasal ...